Corrigendum

In the Drug Profile by Santiago Perez Lloret, María Verónica Rey, Luca Ratti and Olivier Rascol, ‘Pramipexole for the treatment of early Parkinson’s disease’, which appeared in the July 2011 issue of Expert Review of Neurotherapeutics (11[7], 925–935 [2011]; http://www.expert-reviews.com/doi/pdf/10.1586/ern.11.75), it has been brought to our attention that the following inaccuracies appeared:

In the author affiliation, the first author name was presented as:

Santiago Perez Lloret

This should have appeared as:

Santiago Perez-Lloret

In addition, in Table 2 the following columns under Hauser (2010) [32] incorrectly appeared as:

Table

Adverse event	Hauser (2010) [32]
	Placebo	PPX	PPX-ER
N	103	50	106
Anxiety	–	–	–
Depression	–	–	–
Peripheral edema	–	–	–
Headache	–	–	–
Hallucinations	–	–	–
Nausea/vomiting	22 (21.4)	2 (4)	22 (20.8)
Orthostatic hypotension/dizziness	–	–	–
Sleep disorders	–	–	–
Somnolence	34 (33)	7 (14)	34 (32.1)
Constipation	16 (15.5)	–	13 (12.3)
Fatigue	7 (6.8)	1 (2)	7 (6.6)
Asthenia	–	–	–

These should have appeared as:

Table

Adverse event	Hauser (2010) [32]
	Placebo	PPX	PPX-ER
N	50	103	106
Anxiety	–	–	–
Depression	–	–	–
Peripheral edema	–	–	–
Headache	–	–	–
Hallucinations	–	–	–
Nausea/vomiting	2 (4)	22 (21.4)	22 (20.8)
Orthostatic hypotension/dizziness	–	–	–
Sleep disorders	–	–	–
Somnolence	7 (14)	34 (33)	34 (32.1)
Constipation	–	16 (15.5)	13 (12.3)
Fatigue	1 (2)	7 (6.8)	7 (6.6)
Asthenia	–	–	–

The authors and editors of Expert Review of Neurotherapeutics would like to sincerely apologize for any confusion or inconvenience this may have caused.